# APPLIED GENETIC TECHNOLOGIES CORP

APPLIED GENETIC TECHNOLOGIES CORP is a company headquartered in Alachua, FL, United States.

## Company overview

- **Legal name:** APPLIED GENETIC TECHNOLOGIES CORP
- **Classification:** Company
- **Industry (SIC):** 2836 — Biological Products, (No Diagnostic Substances)
- **Headquarters:** Alachua, FL, United States
- **Incorporated in:** DE
- **Fiscal year end:** June 30
- **SEC CIK:** 0001273636

## About

APPLIED GENETIC TECHNOLOGIES CORP is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001273636, and its reported industry is Biological Products, (No Diagnostic Substances). In 10-K filed on 2022-09-27, it reported annual revenue of USD 325,000; net income of USD -68,943,000; total assets of USD 66,684,000 for the fiscal period ended 2022-06-30. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2022 (period ended 2022-06-30)

- **Revenue:** $325,000 (USD 325,000)
- **Net income:** -$68.9M (USD -68,943,000)
- **Total assets:** $66.7M (USD 66,684,000)
- **Cash and equivalents:** $46.4M (USD 46,366,000)
- **Operating cash flow:** -$65.7M (USD -65,748,000)

### FY2021 (period ended 2021-06-30)

- **Revenue:** $500,000 (USD 500,000)
- **Net income:** -$57.8M (USD -57,829,000)
- **Total assets:** $127.0M (USD 126,966,000)
- **Cash and equivalents:** $105.1M (USD 105,052,000)
- **Operating cash flow:** -$51.2M (USD -51,173,000)

### FY2020 (period ended 2020-06-30)

- **Revenue:** $2.5M (USD 2,453,000)
- **Net income:** -$45.9M (USD -45,892,000)
- **Total assets:** $100.3M (USD 100,319,000)
- **Cash and equivalents:** $38.5M (USD 38,463,000)
- **Operating cash flow:** -$41.6M (USD -41,620,000)

### FY2019 (period ended 2019-06-30)

- **Revenue:** $41.7M (USD 41,692,000)
- **Net income:** -$2.0M (USD -2,006,000)
- **Total assets:** $92.2M (USD 92,216,000)
- **Cash and equivalents:** $26.7M (USD 26,703,000)
- **Operating cash flow:** -$23.5M (USD -23,457,000)

## Recent SEC filings

- Form SC 13D — filed 2022-12-08 — APPLIED GENETIC TECHNOLOGIES CORPORATION
- Form 8-K — filed 2022-12-01 — period 2022-11-30 — 8-K
- Form 8-K — filed 2022-11-29 — period 2022-11-29 — 8-K
- Form 8-K — filed 2022-11-23 — period 2022-11-22 — 8-K
- Form 10-Q — filed 2022-11-21 — period 2022-09-30 — 10-Q
- Form SC 13G — filed 2022-11-04
- Form 10-K/A — filed 2022-10-24 — period 2022-06-30 — 10-K/A
- Form 8-K — filed 2022-10-24 — period 2022-10-23 — 8-K
- Form 10-K — filed 2022-09-27 — period 2022-06-30 — 10-K
- Form 8-K — filed 2022-08-26 — period 2022-08-23 — 8-K
- Form 8-K — filed 2022-08-12 — period 2022-08-08 — 8-K
- Form 8-K — filed 2022-07-14 — period 2022-07-12 — 8-K

---

Updated: 2026-10-23T20:12:17Z

Canonical page: https://altss.com/profile/applied-genetic-technologies-corp

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology